ANI Pharmaceuticals
ANIP
#4819
Rank
$1.83 B
Marketcap
$81.77
Share price
-1.17%
Change (1 day)
43.53%
Change (1 year)

Earnings for ANI Pharmaceuticals (ANIP)

Earnings in 2025 (TTM): $50.55 Million USD

According to ANI Pharmaceuticals's latest financial reports the company's current earnings are $0.82 Billion USD. In 2024 the company made an earning of -$22.22 Million USD a decrease over its 2023 earnings that were of $19.87 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ANI Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $50.55 M-327.58%
2024 -$22.22 Million-211.78%
2023 $19.87 M-131.71%
2022 -$62.67 Million11.79%
2021 -$56.06 Million115.92%
2020 -$25.97 Million-922.36%
2019 $3.15 M-84.26%
2018 $20.05 M22.64%
2017 $16.34 M88.4%
2016 $8.67 M-60.07%
2015 $21.73 M12.15%
2014 $19.37 M-899.29%
2013 -$2.43 Million-91.27%
2012 -$27.77 Million-46.02%
2011 -$51.45 Million17.96%
2010 -$43.61 Million18%
2009 -$36.96 Million103.96%
2008 -$18.12 Million128.68%
2007 -$7.93 Million-330.34%
2006 $3.43 M-136.98%
2005 -$9.31 Million-24.17%
2004 -$12.27 Million102.51%
2003 -$6.06 Million58.68%
2002 -$3.82 Million39.58%
2001 -$2.74 Million-24.1%
2000 -$3.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Jazz Pharmaceuticals
JAZZ
-$0.71 Billion-1,490.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
-$4.89 Million-109.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$1.77 B 3,405.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
$11.85 B 23,346.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
-$0.2 Billion-492.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-$0.26 Billion-606.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
$2.42 B 4,689.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$16.41 B 32,380.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Royalty Pharma
RPRX
$1.58 B 3,029.34%๐Ÿ‡ฌ๐Ÿ‡ง UK